Edmund Harrigan's Net Worth
$22.7 Million
Who is Edmund Harrigan?
Edmund Harrigan has an estimated net worth of $22.7 Million. This is based on reported shares across multiple companies, which include INCYTE CORP, Karuna Therapeutics, Inc., ACADIA PHARMACEUTICALS INC, PhaseBio Pharmaceuticals Inc, and BELLICUM PHARMACEUTICALS, INC.
SEC CIK
Edmund Harrigan's CIK is 0001177917
Past Insider Trading and Trends
2020 was Edmund Harrigan's most active year for acquiring shares with 12 total transactions. Edmund Harrigan's most active month to acquire stocks was the month of May. 2020 was Edmund Harrigan's most active year for disposing of shares, totalling 3 transactions. Edmund Harrigan's most active month to dispose stocks was the month of May. 2016 saw Edmund Harrigan paying a total of $32,970.00 for 13,500 shares, this is the most they've acquired in one year. In 2020 Edmund Harrigan cashed out on 50,000 shares for a total of $4,520,900.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INCYTE CORP (INCY) Snapshot price: $57.77
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.57% | 409 |
$60.62 | $24,793.58 | 16.35K |
Jun 28
| |||
Form 4
| +21.58% | 2.83K |
—
|
—
| 15.95K |
Jun 12
| |||
Form 4
| +3.25% | 413 |
$56.97 | $23,528.61 | 13.12K |
Mar 28
| |||
Form 4
| +3.44% | 423 |
$62.79 | $26,560.17 | 12.7K |
Dec 29
| |||
Form 4
| +3.27% | 389 |
$57.77 | $22,472.53 | 12.28K |
Sep 29
| |||
Form 4
| +3.39% | 390 |
$62.25 | $24,277.50 | 11.89K |
Jun 30
| |||
Form 4
| +27.85% | 2.5K |
—
|
—
| 11.5K |
Jun 14
| |||
Form 4
| +3.76% | 326 |
$72.27 | $23,560.02 | 8.99K |
Mar 31
| |||
Form 4
| +3.61% | 302 |
$80.32 | $24,256.64 | 8.67K |
Scheduled
|
Dec 30
| ||
Form 4
| +2.01% | 165 |
$69.59 | $11,482.35 | 8.37K |
Scheduled
|
Oct 19
| ||
Form 4
| +3.14% | 250 |
$66.64 | $16,660.00 | 8.2K |
Scheduled
|
Sep 30
| ||
Form 4
| +3.06% | 236 |
$75.97 | $17,928.92 | 7.95K |
Scheduled
|
Jun 30
| ||
Form 4
| +38.48% | 2.14K |
—
|
—
| 7.72K |
Jun 15
| |||
Form 4
| +4.50% | 240 |
$79.42 | $19,060.80 | 5.57K |
Scheduled
|
Mar 31
| ||
Form 4
| +4.98% | 253 |
$73.40 | $18,570.20 | 5.33K |
Scheduled
|
Dec 31
| ||
Form 4
| +4.89% | 237 |
$68.78 | $16,300.86 | 5.08K |
Scheduled
|
Sep 30
| ||
Form 4
| +4.49% | 208 |
$84.13 | $17,499.04 | 4.84K |
Scheduled
|
Jun 30
| ||
Form 4
| +70.93% | 1.92K |
—
|
—
| 4.63K |
May 26
| |||
Form 4
| +8.79% | 219 |
$81.27 | $17,798.13 | 2.71K |
Scheduled
|
Mar 31
| ||
Form 4
| +9.06% | 207 |
$86.98 | $18,004.86 | 2.49K |
Scheduled
|
Dec 31
| ||
Form 4
| +8.91% | 187 |
$89.74 | $16,781.38 | 2.29K |
Scheduled
|
Sep 30
| ||
Form 4
| +7.81% | 152 |
$103.97 | $15,803.44 | 2.1K |
Scheduled
|
Jun 30
| ||
Form 4
| +193.07% | 1.28K |
—
|
—
| 1.95K |
May 26
| |||
Form 4
| +43.72% | 202 |
$73.23 | $14,792.46 | 664 |
Scheduled
|
Mar 31
| ||
Form 4
|
∞
| 462 |
—
|
—
| 462 |
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Karuna Therapeutics, Inc. (KRTX) Snapshot price: $314.09
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.35% | -10.00K |
$83.32 | -$833,200.00 | 55.16K |
Scheduled
|
Aug 12
| ||
Form 4
| -13.30% | -10.00K |
$93.40 | -$934,000.00 | 65.16K |
Scheduled
|
Jul 13
| ||
Form 4
| -28.53% | -30.00K |
$91.79 | -$2,753,700.00 | 75.16K |
Scheduled
|
Jun 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
∞
| 105.16K |
—
|
—
| 105.16K |
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACADIA PHARMACEUTICALS INC (ACAD) Snapshot price: $25.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +35.01% | 6.65K |
—
|
—
| 25.65K |
May 29
| |||
Form 4
| +1,800.20% | 18K |
—
|
—
| 19K |
Jun 22 - Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
∞
| 1K |
$32.97 | $32,970.00 | 1K |
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PhaseBio Pharmaceuticals Inc (PHASQ) Snapshot price: $0.0002
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +62.50% | 3.75K |
—
|
—
| 9.75K |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
∞
| 6K |
$4.12 | $24,720.00 | 6K |
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BELLICUM PHARMACEUTICALS, INC (BLCM) Snapshot price: $0.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||